Table 1: Demographics and medication of enrolled study subjects.
|
|
SVT patients (n=10) |
CHF patients (n=10) |
Athletes (n=10) |
|
age (yrs) |
44,3±14,5 |
60,4±8,7 |
27,9±6,8 |
|
LVEF (%) |
61,2±4,7 |
35,6±13,2 |
58,4±6,0 |
|
peak VO2 (ml/min/kg) |
n.a. |
n.a. |
51,6±4,2 |
|
betablocker (n) |
0 |
10 |
0 |
|
RAAS-inhibitor (n) |
4 |
10 |
0 |
|
diuretic (n) |
1 |
5 |
0 |
|
statin (n) |
2 |
10 |
0 |
LVEF: left ventricular ejection fraction in transthoracic echocardiography calculated by Simpson’s rule, peak VO2: peak O2 uptake during maximal cardiopulmonary exercise treadmill exercise test; these values are given in mean ± SD; RAAS-inhibitors: Angiotensin-converting-enzyme-inhibitors or angiotensin-2 receptor blockers; for medication the number of subjects within a group on a specific drug is given (n).